The Impact of COVID-19 on the Diagnosis and Treatment of Breast Cancer (TICTOC): a population-based study
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202111WI1
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$234,566.8Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
University Health NetworkResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
Digital Health
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Minority communities unspecified
Occupations of Interest
Unspecified
Abstract
INTRODUCTION: During the COVID-19 pandemic, there were limitations in healthcare resources which led to restricted access to breast cancer screening and treatment. These limitations have the potential to further exacerbate pre-existing disparities in breast cancer care. METHODS: We will use linked healthcare administrative databases in Ontario to assess for regional variations in breast cancer screening and treatment. We will also explore breast cancer care during the pandemic for marginalized patients. Lastly, we will determine the impact of virtual care and virtual multidisciplinary cancer conferences on breast cancer care during the pandemic. SIGNIFICANCE: This study will the first population-based study in Canada to describe patterns of breast cancer screening and treatment during the pandemic between regions and among marginalized populations. Results from this study will help inform future research and policies on breast cancer care after the pandemic.